Literature DB >> 30869999

Identifying Women at High Risk for Breast Cancer Using Data From the Electronic Health Record Compared With Self-Report.

Xinyi Jiang1, Julia E McGuinness1, Margaret Sin1, Thomas Silverman1, Rita Kukafka1, Katherine D Crew1,2.   

Abstract

PURPOSE: A barrier to chemoprevention uptake among high-risk women is the lack of routine breast cancer risk assessment in the primary care setting. We calculated breast cancer risk using the Breast Cancer Surveillance Consortium (BCSC) model, accounting for age, race/ethnicity, first-degree family history of breast cancer, benign breast disease, and mammographic density, using data collected from the electronic health records (EHRs) and self-reports. PATIENTS AND METHODS: Among women undergoing screening mammography, we enrolled those age 35 to 74 years without a prior history of breast cancer. Data on demographics, first-degree family history, breast radiology, and pathology reports were extracted from the EHR. We assessed agreement between the EHR and self-report on information about breast cancer risk.
RESULTS: Among 9,514 women with known race/ethnicity, 1,443 women (15.2%) met high-risk criteria based upon a 5-year invasive breast cancer risk of 1.67% or greater according to the BCSC model. Among 1,495 women with both self-report and EHR data, more women with a first-degree family history of breast cancer (14.6% v 4.4%) and previous breast biopsies (21.3% v 11.3%) were identified by self-report versus EHR, respectively. However, more women with atypia and lobular carcinoma in situ were identified from the EHR. There was moderate agreement in identification of high-risk women between EHR and self-report data (κ, 0.48; 95% CI, 0.42-0.54).
CONCLUSION: By using EHR data, we determined that 15% of women undergoing screening mammography had a high risk for breast cancer according to the BCSC model. There was moderate agreement between information on breast cancer risk derived from the EHR and self-report. Examining EHR data may serve as an initial screen for identifying women eligible for breast cancer chemoprevention.

Entities:  

Mesh:

Year:  2019        PMID: 30869999      PMCID: PMC6874029          DOI: 10.1200/CCI.18.00072

Source DB:  PubMed          Journal:  JCO Clin Cancer Inform        ISSN: 2473-4276


  27 in total

1.  Breast cancer risk reduction options: awareness, discussion, and use among women from four ethnic groups.

Authors:  Celia Patricia Kaplan; Jennifer S Haas; Eliseo J Pérez-Stable; Steven E Gregorich; Carol Somkin; Genevieve Des Jarlais; Karla Kerlikowske
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-01       Impact factor: 4.254

2.  Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database.

Authors:  R Ballard-Barbash; S H Taplin; B C Yankaskas; V L Ernster; R D Rosenberg; P A Carney; W E Barlow; B M Geller; K Kerlikowske; B K Edwards; C F Lynch; N Urban; C A Chrvala; C R Key; S P Poplack; J K Worden; L G Kessler
Journal:  AJR Am J Roentgenol       Date:  1997-10       Impact factor: 3.959

3.  Awareness of breast density and its impact on breast cancer detection and risk.

Authors:  Deborah J Rhodes; Carmen Radecki Breitkopf; Jeanette Y Ziegenfuss; Sarah M Jenkins; Celine M Vachon
Journal:  J Clin Oncol       Date:  2015-03-02       Impact factor: 44.544

4.  Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women.

Authors:  Rayna K Matsuno; Joseph P Costantino; Regina G Ziegler; Garnet L Anderson; Huilin Li; David Pee; Mitchell H Gail
Journal:  J Natl Cancer Inst       Date:  2011-05-11       Impact factor: 13.506

5.  Validation studies for models projecting the risk of invasive and total breast cancer incidence.

Authors:  J P Costantino; M H Gail; D Pee; S Anderson; C K Redmond; J Benichou; H S Wieand
Journal:  J Natl Cancer Inst       Date:  1999-09-15       Impact factor: 13.506

6.  Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.

Authors:  Bernard Fisher; Joseph P Costantino; D Lawrence Wickerham; Reena S Cecchini; Walter M Cronin; Andre Robidoux; Therese B Bevers; Maureen T Kavanah; James N Atkins; Richard G Margolese; Carolyn D Runowicz; Joan M James; Leslie G Ford; Norman Wolmark
Journal:  J Natl Cancer Inst       Date:  2005-11-16       Impact factor: 13.506

7.  Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer.

Authors:  Victor G Vogel; Joseph P Costantino; D Lawrence Wickerham; Walter M Cronin; Reena S Cecchini; James N Atkins; Therese B Bevers; Louis Fehrenbacher; Eduardo R Pajon; James L Wade; André Robidoux; Richard G Margolese; Joan James; Carolyn D Runowicz; Patricia A Ganz; Steven E Reis; Worta McCaskill-Stevens; Leslie G Ford; V Craig Jordan; Norman Wolmark
Journal:  Cancer Prev Res (Phila)       Date:  2010-04-19

8.  Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model.

Authors:  Jeffrey A Tice; Steven R Cummings; Rebecca Smith-Bindman; Laura Ichikawa; William E Barlow; Karla Kerlikowske
Journal:  Ann Intern Med       Date:  2008-03-04       Impact factor: 25.391

9.  Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model.

Authors:  Nora Pashayan; Steve Morris; Fiona J Gilbert; Paul D P Pharoah
Journal:  JAMA Oncol       Date:  2018-11-01       Impact factor: 31.777

10.  Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial.

Authors:  Jack Cuzick; Ivana Sestak; Simon Cawthorn; Hisham Hamed; Kaija Holli; Anthony Howell; John F Forbes
Journal:  Lancet Oncol       Date:  2014-12-11       Impact factor: 41.316

View more
  7 in total

1.  Mental Illness and BRCA1/2 Genetic Testing Intention Among Multiethnic Women Undergoing Screening Mammography.

Authors:  Tarsha Jones; Katherine Freeman; Marra Ackerman; Meghna S Trivedi; Thomas Silverman; Peter Shapiro; Rita Kukafka; Katherine D Crew
Journal:  Oncol Nurs Forum       Date:  2020-01-01       Impact factor: 2.172

2.  Extraction of Electronic Health Record Data using Fast Healthcare Interoperability Resources for Automated Breast Cancer Risk Assessment.

Authors:  Julia E McGuinness; Tianmai M Zhang; Kevin Cooper; Arusha Kelkar; Jill Dimond; Virginia Lorenzi; Katherine D Crew; Rita Kukafka
Journal:  AMIA Annu Symp Proc       Date:  2022-02-21

3.  Patient and Provider Web-Based Decision Support for Breast Cancer Chemoprevention: A Randomized Controlled Trial.

Authors:  Katherine D Crew; Gauri Bhatkhande; Thomas Silverman; Jacquelyn Amenta; Tarsha Jones; Julia E McGuinness; Jennie Mata; Ashlee Guzman; Ting He; Jill Dimond; Wei-Yann Tsai; Rita Kukafka
Journal:  Cancer Prev Res (Phila)       Date:  2022-10-04

4.  Strategies to Identify and Recruit Women at High Risk for Breast Cancer to a Randomized Controlled Trial of Web-based Decision Support Tools.

Authors:  Julia E McGuinness; Gauri Bhatkhande; Jacquelyn Amenta; Thomas Silverman; Jennie Mata; Ashlee Guzman; Ting He; Jill Dimond; Tarsha Jones; Rita Kukafka; Katherine D Crew
Journal:  Cancer Prev Res (Phila)       Date:  2022-06-02

5.  Searching the PDF Haystack: Automated Knowledge Discovery in Scanned EHR Documents.

Authors:  Alexander L Kostrinsky-Thomas; Fuki M Hisama; Thomas H Payne
Journal:  Appl Clin Inform       Date:  2021-03-24       Impact factor: 2.342

6.  Effect of Personalized Breast Cancer Risk Tool on Chemoprevention and Breast Imaging: ENGAGED-2 Trial.

Authors:  Karen J Wernli; Sarah Knerr; Tengfei Li; Kathleen Leppig; Kelly Ehrlich; David Farrell; Hongyuan Gao; Erin J A Bowles; Amanda L Graham; George Luta; Jinani Jayasekera; Jeanne S Mandelblatt; Marc D Schwartz; Suzanne C O'Neill
Journal:  JNCI Cancer Spectr       Date:  2021-01-14

7.  Study protocol: Randomized controlled trial of web-based decision support tools for high-risk women and healthcare providers to increase breast cancer chemoprevention.

Authors:  Katherine D Crew; Thomas B Silverman; Alejandro Vanegas; Meghna S Trivedi; Jill Dimond; Jennie Mata; Margaret Sin; Tarsha Jones; Mary Beth Terry; Wei-Yann Tsai; Rita Kukafka
Journal:  Contemp Clin Trials Commun       Date:  2019-08-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.